BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 22626471)

  • 1. Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer.
    Chaneton B; Gottlieb E
    Trends Biochem Sci; 2012 Aug; 37(8):309-16. PubMed ID: 22626471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual roles of PKM2 in cancer metabolism.
    Wu S; Le H
    Acta Biochim Biophys Sin (Shanghai); 2013 Jan; 45(1):27-35. PubMed ID: 23212076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PKM2 contributes to cancer metabolism.
    Wong N; Ojo D; Yan J; Tang D
    Cancer Lett; 2015 Jan; 356(2 Pt A):184-91. PubMed ID: 24508027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKM2, cancer metabolism, and the road ahead.
    Dayton TL; Jacks T; Vander Heiden MG
    EMBO Rep; 2016 Dec; 17(12):1721-1730. PubMed ID: 27856534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyruvate kinase type M2 contributes to the development of pancreatic ductal adenocarcinoma by regulating the production of metabolites and reactive oxygen species.
    Yokoyama M; Tanuma N; Shibuya R; Shiroki T; Abue M; Yamamoto K; Miura K; Yamaguchi K; Sato I; Tamai K; Satoh K
    Int J Oncol; 2018 Mar; 52(3):881-891. PubMed ID: 29393401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-(sulfonyl)-5-(arylsulfonyl)indoline as activators of the tumor cell specific M2 isoform of pyruvate kinase.
    Yacovan A; Ozeri R; Kehat T; Mirilashvili S; Sherman D; Aizikovich A; Shitrit A; Ben-Zeev E; Schutz N; Bohana-Kashtan O; Konson A; Behar V; Becker OM
    Bioorg Med Chem Lett; 2012 Oct; 22(20):6460-8. PubMed ID: 22963766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells.
    Mazurek S
    Int J Biochem Cell Biol; 2011 Jul; 43(7):969-80. PubMed ID: 20156581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activators of PKM2 in cancer metabolism.
    Warner SL; Carpenter KJ; Bearss DJ
    Future Med Chem; 2014 Jun; 6(10):1167-78. PubMed ID: 25078136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyruvate kinase M2: multiple faces for conferring benefits on cancer cells.
    Tamada M; Suematsu M; Saya H
    Clin Cancer Res; 2012 Oct; 18(20):5554-61. PubMed ID: 23071357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of pyruvate kinase M2 and lactate dehydrogenase A by fibroblast growth factor receptor 1 in benign and malignant thyroid tissue.
    Kachel P; Trojanowicz B; Sekulla C; Prenzel H; Dralle H; Hoang-Vu C
    BMC Cancer; 2015 Mar; 15():140. PubMed ID: 25880801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway.
    Fukuda S; Miyata H; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1461-8. PubMed ID: 25808097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging roles of PKM2 in cell metabolism and cancer progression.
    Luo W; Semenza GL
    Trends Endocrinol Metab; 2012 Nov; 23(11):560-6. PubMed ID: 22824010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in PKM2 associate with prostate cancer progression.
    Wong N; Yan J; Ojo D; De Melo J; Cutz JC; Tang D
    Cancer Invest; 2014 Aug; 32(7):330-8. PubMed ID: 24884829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The responsively decreased PKM2 facilitates the survival of pancreatic cancer cells in hypoglucose.
    Li X; Deng S; Liu M; Jin Y; Zhu S; Deng S; Chen J; He C; Qin Q; Wang C; Zhao G
    Cell Death Dis; 2018 Jan; 9(2):133. PubMed ID: 29374159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transcription factor TEAD4 enhances lung adenocarcinoma progression through enhancing PKM2 mediated glycolysis.
    Hu Y; Mu H; Deng Z
    Cell Biol Int; 2021 Oct; 45(10):2063-2073. PubMed ID: 34196069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antioxidant uncoupling protein 2 stimulates hnRNPA2/B1, GLUT1 and PKM2 expression and sensitizes pancreas cancer cells to glycolysis inhibition.
    Brandi J; Cecconi D; Cordani M; Torrens-Mas M; Pacchiana R; Dalla Pozza E; Butera G; Manfredi M; Marengo E; Oliver J; Roca P; Dando I; Donadelli M
    Free Radic Biol Med; 2016 Dec; 101():305-316. PubMed ID: 27989750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolism enzyme controls cancer stemness].
    Konno M; Doki Y; Mori M; Ishii H
    Nihon Rinsho; 2015 May; 73(5):745-50. PubMed ID: 25985625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PKM2-dependent glycolysis promotes the proliferation and migration of vascular smooth muscle cells during atherosclerosis.
    Zhao X; Tan F; Cao X; Cao Z; Li B; Shen Z; Tian Y
    Acta Biochim Biophys Sin (Shanghai); 2020 Jan; 52(1):9-17. PubMed ID: 31867609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyruvate kinase M2 and cancer: an updated assessment.
    Iqbal MA; Gupta V; Gopinath P; Mazurek S; Bamezai RN
    FEBS Lett; 2014 Aug; 588(16):2685-92. PubMed ID: 24747424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PKM2 promotes glucose metabolism through a let-7a-5p/Stat3/hnRNP-A1 regulatory feedback loop in breast cancer cells.
    Yao A; Xiang Y; Si YR; Fan LJ; Li JP; Li H; Guo W; He HX; Liang XJ; Tan Y; Bao LY; Liao XH
    J Cell Biochem; 2019 Apr; 120(4):6542-6554. PubMed ID: 30368881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.